Aptose Reports FY23 Loss Per Share Of $(7.58) vs $(6.80) Loss Last Year
Portfolio Pulse from Benzinga Newsdesk
Aptose Biosciences reported a fiscal year 2023 loss per share of $(7.58), compared to a loss of $(6.80) per share in the previous year.
March 26, 2024 | 8:06 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Aptose Biosciences reported a larger loss per share for fiscal year 2023, indicating a negative trend in its financial performance.
The reported increase in loss per share for Aptose Biosciences from the previous fiscal year suggests a deterioration in the company's financial health, which could negatively impact investor sentiment and potentially lead to a decrease in stock price in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100